One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1200/jco.2018.36.15_suppl.e23502
Copy DOI
Export
Save
Share
Cite Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2018 |
Affiliation: Istituto Ortopedico Rizzoli, University of Palermo, European Institute of Oncology, Istituto Oncologico Veneto, Ospedale Humanitas Gradenigo, Candiolo Cancer Institute, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Ospedale Papa Giovanni XXIII, Università Campus Bio-Medico, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Policlinico di Modena, Fondazione IRCCS Istituto Nazionale dei Tumori
e23502Background: Trabectedin (T) is approved for patients (pts) with STS after failure of anthracyclines (A) and ifosfamide (I), or pts unsuited to receive AI. ISG performed a retrospective study ...
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
